![Douglas Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Hughes
Direttore/Membro del Consiglio presso
IMMUNOVANT, INC.
Patrimonio netto: 4 M $ in data 31/05/2026
Profilo
Douglas Hughes is currently Director at Immunovant Sciences Ltd. since 2019, Independent Director at Immunovant, Inc. since 2019, Chief Financial Officer & Director at Calyxo, Inc. since 2018, and Chief Financial Officer at Calyxo USA, Inc. since 2019.
Former roles include Director-Investor Relations at The Clorox Co., Independent Non-Executive Director at Eargo, Inc. from 2020 to 2022, Director at Immunovant, Inc., Vice President-Investor Relations at Guidant Corp., Vice President-Finance & Administration at Boston Scientific Corp., Chief Operating & Financial Officer at Nellix, Inc. from 2010 to 2011, Chief Financial Officer at NeoTract, Inc. from 2011 to 2018, Chief Financial Officer at Evalve, Inc. from 2009 to 2010, and Chief Financial Officer at Maquet.
Education includes an MBA from The University of Chicago and undergraduate studies at San Francisco State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOVANT INC 0,07% | 07/04/2026 | 134.653 ( 0,07% ) | 4 M $ | 31/05/2026 |
Posizioni attive di Douglas Hughes
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOVANT, INC. | Direttore/Membro del Consiglio | 18/12/2019 |
Calyxo USA, Inc.
 Calyxo USA, Inc. Engineering & ConstructionIndustrial Services Develops solar energy | Direttore Finanziario/CFO | 01/01/2019 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Direttore/Membro del Consiglio | 01/10/2019 |
Calyxo, Inc.
 Calyxo, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for kidney stone disease treatment | Direttore Finanziario/CFO | 01/01/2018 |
Precedenti posizioni note di Douglas Hughes
| Società | Posizione | Fine |
|---|---|---|
| EARGO, INC. | Direttore/Membro del Consiglio | 07/12/2022 |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology Develops surgical devices for urological and gynecological disorders | Direttore Finanziario/CFO | 01/01/2018 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Public Communications Contact | 01/04/2011 |
Nellix, Inc.
 Nellix, Inc. Medical SpecialtiesHealth Technology Develops novel solutions to vascular diseases | Direttore Finanziario/CFO | 01/01/2011 |
Evalve, Inc.
 Evalve, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices | Direttore Finanziario/CFO | 01/01/2010 |
Formazione di Douglas Hughes
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
16
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
The Clorox Co.
 The Clorox Co. Household/Personal CareConsumer Non-Durables Manufactures and markets cleaning, disinfection, bags, wraps, food & cat litter products | Consumer Non-Durables |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Nellix, Inc.
Nellix, Inc. Medical SpecialtiesHealth Technology Develops novel solutions to vascular diseases | Health Technology |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology Develops surgical devices for urological and gynecological disorders | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices | Health Technology |
Maquet
 Maquet Medical DistributorsDistribution Services Wholesales medical equipment | Distribution Services |
Calyxo USA, Inc.
Calyxo USA, Inc. Engineering & ConstructionIndustrial Services Develops solar energy | Industrial Services |
Eargo, Inc.
 Eargo, Inc. Medical SpecialtiesHealth Technology Designs and manufactures hearing aids | Health Technology |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for kidney stone disease treatment | Health Technology |
